Riebe Michael T 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
Riebe Michael T
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2020-12-03+20,000→ 20,000 totalExercise: $4.60Exp: 2030-12-03→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting.
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Michael T, Riebe, Ph.D.|2020-12-07